Overview
Hirokazu Tachikawa practices practicing medicine in Tsukuba, Japan.
Tachikawa is highly rated in 1 condition, according to our data. Their clinical expertise encompasses COVID-19, Severe Acute Respiratory Syndrome (SARS), and Major Depression.
They are actively involved in clinical research, co-authoring 72 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hirokazu Tachikawa
Is Hirokazu Tachikawa a top-rated expert for COVID-19?
MediFind is an objective health platform that identifies experts based on real-world data. Hirokazu Tachikawa is classified as an Advanced expert for COVID-19, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hirokazu Tachikawa participate in research or clinical trials?
Yes. Hirokazu Tachikawa has published 72 articles and abstracts on conditions like COVID-19. You can view a list of Hirokazu Tachikawa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- COVID-19Tachikawa isAdvanced. Learn about COVID-19.
- Experienced
- Major DepressionTachikawa isExperienced. Learn about Major Depression.
- Severe Acute Respiratory Syndrome (SARS)